Nanozora (ozoralizumab)

£2,196.72

Nanozora (ozoralizumab) is a prescription medicine indicated for the treatment of rheumatoid arthritis (RA)1.

Nanozora (ozoralizumab) is approved by the PMDA in Japan1.

DISEASE INDICATIONS

Rheumatoid Arthritis

MANUFACTURER

 

USAGE

Subcutaneous

MEDICINE APPROVED BY

  • Pharmaceuticals and Medical Devices Agency (PMDA)

PATIENTS HELPED

  • Over 1.2 million patients reached

  • More than 11,000 patients helped

  • 100% successful deliveries to 88 countries

WE CAN HELP WITH YOUR IMPORT DOCUMENTS

We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
NANOZORA (OZORALIZUMAB) Package

1 Pre-filled syringe of 0,375 mL x 30 mg

Reviews

There are no reviews yet.

Be the first to review “Nanozora (ozoralizumab)”

Your email address will not be published. Required fields are marked *

Shopping Cart